NPM1-PTMA and HIST1H2BO-YBX1 fusion transcripts have a significant impact on the overall survival of patients with laterally spreading tumors of CRC and can be used as prognostic and diagnostic biomarkers [16]. This evidence concerns the gene YBX1 and colorectal carcinoma.